Lexeo Therapeutics (LXEO) EPS (Weighted Average and Diluted): 2022-2024
Historic EPS (Weighted Average and Diluted) for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$3.09.
- Lexeo Therapeutics' EPS (Weighted Average and Diluted) rose 323.93% to $19.84 in Q4 2023 from the same period last year, while for Dec 2023 it was -$12.40, marking a year-over-year change of. This contributed to the annual value of -$3.09 for FY2024, which is 75.08% up from last year.
- Latest data reveals that Lexeo Therapeutics reported EPS (Weighted Average and Diluted) of -$3.09 as of FY2024, which was up 75.08% from -$12.40 recorded in FY2023.
- In the past 5 years, Lexeo Therapeutics' EPS (Weighted Average and Diluted) registered a high of -$3.09 during FY2024, and its lowest value of -$36.36 during FY2022.
- Over the past 3 years, Lexeo Therapeutics' median EPS (Weighted Average and Diluted) value was -$12.40 (recorded in 2023), while the average stood at -$17.28.
- Data for Lexeo Therapeutics' EPS (Weighted Average and Diluted) shows a peak YoY spiked of 75.08% (in 2024) over the last 5 years.
- Yearly analysis of 3 years shows Lexeo Therapeutics' EPS (Weighted Average and Diluted) stood at -$36.36 in 2022, then spiked by 65.90% to -$12.40 in 2023, then skyrocketed by 75.08% to -$3.09 in 2024.